Market World Cardiac Biomarkers Market Outlook | Page 2

Type Insights
Based on the types, the cardiac biomarker market is classified into the troponin, creatinine- kinase MB,
Natriuretic peptides- b-type Natriuretic peptide and N terminal pro b–type Natriuretic peptide, myoglobin, and
others. Troponin tests are in large demand for the detection of the AMI with efficient diagnosis of cardiovascular
disorders. This growing demand has resulted in tremendous market growth of this segment.
Natriuretic peptides held the second largest share in 2015. The increasing incidence of the cardiovascular
disorders has led to the surge in demand of these products, further attributing to the growth of the segment.
Application Insights
Based on application, the market is segmented into ACS (acute coronary syndrome), AMI (acute myocardial
infarction), and CHF (congestive heart failure). The cardiac biomarkers have major application in the diagnosis
of ACS and thus, this segment accounted for largest revenue generating sector. According to American Heart
Association (AHA), the Americans are estimated to spend around USD 150 billion for treating ACS posing a huge
social and economic burden.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/cardiac-biomarker-market
Followed by ACS, myocardial infarction held the second largest market share in 2015. The increasing number of
the geriatric population has led to the growth of the sector, in this segment, as the elderly population is more
prone to cardiac-related ailments. In addition, the growing unhealthy, sedentary lifestyle and alcohol
consumption has further augmented the chances of the heart problems, hence, boosting the cardiac biomarker
market growth.
End User Insights
The end user segment is fragmented into two types namely, laboratory testing and point of testing (PoC). The
laboratory testing held the largest revenue share in 2015. Increasing incidence and prevalence of heart-related
diseases is expected to flourish the segment growth.
The PoC testing segment is projected to witness growth at the highest CAGR during the forecast period. The
rising demand for the PoC segment has led to the growth of the segment. Moreover, the rising awareness in the
developing countries regarding the use of PoC testing and its application in cardiac biomarkers has nurtured the
market growth.